Portola Pharmaceuticals, Inc.
(NASDAQ : PTLA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.25%15.211.8%$131.96m
VRXValeant Pharmaceuticals International, Inc.
-3.46%21.3414.1%$125.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.28%145.466.2%$78.47m
PRGOPerrigo Co. Plc
-2.91%46.386.8%$67.08m
SAGESAGE Therapeutics, Inc.
0.11%169.308.6%$65.12m
JAZZJazz Pharmaceuticals Plc
-1.39%129.002.3%$52.46m
HZNPHorizon Pharma plc
-1.77%27.196.7%$42.82m
PTLAPortola Pharmaceuticals, Inc.
-3.51%27.807.5%$41.62m
UTHRUnited Therapeutics Corporation
-2.58%80.7114.3%$39.76m
MDCOMedicines Company
-2.12%35.0320.3%$37.35m
ICLRICON Plc
-1.86%153.414.1%$35.69m
CTLTCatalent Inc
-3.86%53.112.4%$35.12m
ICPTIntercept Pharmaceuticals, Inc.
-3.30%60.9017.2%$33.13m
ZGNXZogenix, Inc.
-2.82%50.019.8%$22.94m
AERIAerie Pharmaceuticals, Inc.
-2.30%23.426.8%$22.84m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.